Soji Kakiuchi

2.4k citations

41 papers · 1.9k indexed · 1 hit paper · h-index 21

Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 2%
Oncology top 5%
Cancer Research top 5%
Immunology

Co-authors: Saburo Sone Seiji Yano Yasuhiko Nishioka Masaki Hanibuchi Hisanori Uehara Hirokazu Ogino Yataro Daigo Tatsuhiko Tsunoda
Topics: Lung Cancer Treatments and Mutations (17 papers)Lung Cancer Research Studies (10 papers)Occupational and environmental lung diseases (9 papers)
Cited by: Oncology Pulmonary and Respiratory Medicine Cancer Research
Journals: Nature Communications Cancer Research Oncogene
Partner nations: Japan United Kingdom United States

In The Last Decade

Soji Kakiuchi

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

2008 513 citations Seiji Yano, Wei Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by Soji Kakiuchi

Since Specialization

Citations

This map shows the geographic impact of Soji Kakiuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soji Kakiuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soji Kakiuchi more than expected).

Fields of papers citing papers by Soji Kakiuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soji Kakiuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soji Kakiuchi. The network helps show where Soji Kakiuchi may publish in the future.

Co-authorship network of co-authors of Soji Kakiuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Soji Kakiuchi. A scholar is included among the top collaborators of Soji Kakiuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soji Kakiuchi. Soji Kakiuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol 2024 ·Cureus ·(unknown),Soji Kakiuchi,(unknown),Naoya Murakami,Takashi Haku	0
2	The clinical features of older patients with lung cancer in comparison with their younger counterparts 2018 ·Respiratory Investigation ·Hirokazu Ogino,Masaki Hanibuchi,Satoshi Sakaguchi,Yuko Toyoda,(unknown),Hiroshi Kawano,Soji Kakiuchi,Kenji Otsuka,Atsuro Saijo,Masahiko Azuma,Hiroshi Nokihara,Hisatsugu Goto,Yasuhiko Nishioka	4
3	A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease 2018 ·Lung Cancer ·Masaki Hanibuchi,Soji Kakiuchi,Shinji Atagi,Fumitaka Ogushi,Eiji Shimizu,Takashi Haku,Yuko Toyoda,Masahiko Azuma,(unknown),Hiroshi Kawano,Kenji Otsuka,Satoshi Sakaguchi,Hiroshi Nokihara,Hisatsugu Goto,Yasuhiko Nishioka	20
4	Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated Macrophages 2013 ·American Journal Of Pathology ·Atsushi Mitsuhashi,Hisatsugu Goto,Takuya Kuramoto,Sho Tabata,(unknown),Shinji Abe,Masaki Hanibuchi,Soji Kakiuchi,Atsuro Saijo,Yoshinori Aono,Hisanori Uehara,Seiji Yano,Julie G. Ledford,Saburo Sone,Yasuhiko Nishioka	48
5	Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB Activity 2012 ·Molecular Cancer Therapeutics ·Takuya Kuramoto,Hisatsugu Goto,Atsushi Mitsuhashi,Sho Tabata,Hirohisa Ogawa,Hisanori Uehara,Atsuro Saijo,Soji Kakiuchi,Yoichi Maekawa,Koji Yasutomo,Masaki Hanibuchi,Shin-ichi Akiyama,Saburo Sone,Yasuhiko Nishioka	41
6	SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model 2012 ·Respirology ·(unknown),Masaki Hanibuchi,Hisatsugu Goto,Takuya Kuramoto,(unknown),Soji Kakiuchi,Seidai Sato,Satoshi Sakaguchi,(unknown),Yasuhiko Nishioka,Shin‐ichi Akiyama,Saburo Sone	11
7	Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment 2012 ·Clinical & Experimental Metastasis ·Seidai Sato,Masaki Hanibuchi,Takuya Kuramoto,(unknown),Hisatsugu Goto,Hirohisa Ogawa,Atsushi Mitsuhashi,(unknown),Soji Kakiuchi,Shin‐ichi Akiyama,Yasuhiko Nishioka,Saburo Sone	29
8	E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor 2011 ·Molecular Cancer Therapeutics ·Hirokazu Ogino,Masaki Hanibuchi,Soji Kakiuchi,(unknown),Hisatsugu Goto,Kenji Ikuta,Tadaaki Yamada,Hisanori Uehara,Akihiko Tsuruoka,Toshimitsu Uenaka,Wei Wang,Qi Li,Shinji Takeuchi,Seiji Yano,Yasuhiko Nishioka,Saburo Sone	16
9	A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer 2011 ·Oncology Letters ·(unknown),Masaki Hanibuchi,Fumitaka Ogushi,Yoshio Okano,Tsutomu Shinohara,Hiroyuki Doi,(unknown),Eiji Takeuchi,Akihiko Yamamoto,Masahiko Azuma,(unknown),Takanori Kanematsu,Soji Kakiuchi,Hisatsugu Goto,Seiji Yano,Yasuhiko Nishioka,Saburo Sone	3
10	Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice 2010 ·Clinical & Experimental Metastasis ·Satoshi Sakaguchi,Hisatsugu Goto,Masaki Hanibuchi,(unknown),Hirokazu Ogino,Soji Kakiuchi,Hisanori Uehara,Seiji Yano,Yasuhiko Nishioka,Saburo Sone	9
11	The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice 2010 ·Cancer Chemotherapy and Pharmacology ·(unknown),Masaki Hanibuchi,Soji Kakiuchi,Seidai Sato,Takuya Kuramoto,Hisatsugu Goto,Atsushi Mitsuhashi,Yasuhiko Nishioka,Shin‐ichi Akiyama,Saburo Sone	8
12	Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement 2009 ·Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) ·Hirokazu Ogino,Seiji Yano,Soji Kakiuchi,Tadaaki Yamada,Kenji Ikuta,Emiko Nakataki,Hisatsugu Goto,Masaki Hanibuchi,Yasuhiko Nishioka,Anderson J. Ryan,Saburo Sone	17
13	A Bone Metastasis Model With Osteolytic and Osteoblastic Properties of Human Lung Cancer ACC-LC-319/bone2 in Natural Killer Cell-Depleted Severe Combined Immunodeficient Mice 2009 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown),Masaki Hanibuchi,Kenji Ikuta,Seiji Yano,Hisatsugu Goto,Hirokazu Ogino,Tadaaki Yamada,Soji Kakiuchi,Yasuhiko Nishioka,Takashi Takahashi,Saburo Sone	15
14	Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutationsbreakdown → 2008 ·Cancer Research ·Seiji Yano,Wei Wang,Qi Li,Kunio Matsumoto,(unknown),Takahiro Nakamura,Hirokazu Ogino,Soji Kakiuchi,Masaki Hanibuchi,Yasuhiko Nishioka,Hisanori Uehara,Tetsuya Mitsudomi,Yasushi Yatabe,Toshikazu Nakamura,Saburo Sone	513
15	HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody 2008 ·Cancer Immunology Immunotherapy ·Wei Wang,Yasuhiko Nishioka,Shuji Ozaki,Ali Jalili,Shinji Abe,Soji Kakiuchi,(unknown),Kazuo Minakuchi,Toshio Matsumoto,Saburo Sone	54
16	Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement 2008 ·Cancer Letters ·Hirokazu Ogino,Seiji Yano,Soji Kakiuchi,Tadaaki Yamada,Kenji Ikuta,Emiko Nakataki,Hisatsugu Goto,Masaki Hanibuchi,Yasuhiko Nishioka,Anderson J. Ryan,Saburo Sone	1
17	Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA₁ and LPA₂ 2008 ·Cancer Science ·Tadaaki Yamada,Seiji Yano,Hirokazu Ogino,Kenji Ikuta,Soji Kakiuchi,Masaki Hanibuchi,Takanori Kanematsu,Tetsuo Taniguchi,Yoshitaka Sekido,Saburo Sone	20
18	Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES‐10 cells) highly expressing vascular endothelial growth factor and its receptor 2006 ·Cancer Science ·Emiko Nakataki,Seiji Yano,(unknown),Hisatsugu Goto,Soji Kakiuchi,Hiroaki Muguruma,Yoshiyuki Bando,Hisanori Uehara,Hironobu Hamada,Katsumi Kito,Akihito Yokoyama,Saburo Sone	40
19	Reveromycin A Inhibits Osteolytic Bone Metastasis of Small-Cell Lung Cancer Cells, SBC-5, through an Antiosteoclastic Activity 2005 ·Clinical Cancer Research ·Hiroaki Muguruma,Seiji Yano,Soji Kakiuchi,Hisanori Uehara,Makoto Kawatani,Hiroyuki Osada,Saburo Sone	39
20	Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839) 2004 ·Human Molecular Genetics ·Soji Kakiuchi,Yataro Daigo,Nobuhisa Ishikawa,Chiyuki Furukawa,Tatsuhiko Tsunoda,Seiji Yano,Kazuhiko Nakagawa,Takashi Tsuruo,Nobuoki Kohno,Masahiro Fukuoka,Saburo Sone,Yusuke Nakamura	145

About Soji Kakiuchi

Soji Kakiuchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Biotechnology, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (10 papers) and Occupational and environmental lung diseases (9 papers). The work is most often cited by research in Oncology (850 citations), Pulmonary and Respiratory Medicine (910 citations) and Cancer Research (313 citations). Soji Kakiuchi has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Saburo Sone, Seiji Yano, Yasuhiko Nishioka, Masaki Hanibuchi, Hisanori Uehara, Hirokazu Ogino, Yataro Daigo, Tatsuhiko Tsunoda, Wei Wang and Hisatsugu Goto. Their work appears in journals such as Nature Communications, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact